vs
Teladoc Health, Inc.（TDOC）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
Teladoc Health, Inc.的季度营收约是Oncology Institute, Inc.的4.5倍（$642.3M vs $142.0M）。Oncology Institute, Inc.同比增速更快（41.6% vs 0.3%）。Teladoc Health, Inc.自由现金流更多（$85.1M vs $2.2M）。过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs -0.3%）
泰莱达克健康是一家跨国远程医疗与虚拟医疗企业，2002年成立，总部位于美国纽约。公司核心业务涵盖远程问诊、医学意见咨询、人工智能与数据分析、远程医疗设备及可授权平台服务，主要通过电话、视频会议软件与移动应用，为用户提供随时可及的远程医疗服务。
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
TDOC vs TOI — 直观对比
营收规模更大
TDOC
是对方的4.5倍
$142.0M
营收增速更快
TOI
高出41.3%
0.3%
自由现金流更多
TDOC
多$83.0M
$2.2M
两年增速更快
TOI
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $642.3M | $142.0M |
| 净利润 | — | $-7.5M |
| 毛利率 | — | — |
| 营业利润率 | -5.6% | -4.9% |
| 净利率 | — | -5.3% |
| 营收同比 | 0.3% | 41.6% |
| 净利润同比 | — | 43.0% |
| 每股收益（稀释后） | $-0.14 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TDOCTOI
| Q4 25 | $642.3M | $142.0M | ||
| Q3 25 | $626.4M | $136.6M | ||
| Q2 25 | $631.9M | $119.8M | ||
| Q1 25 | $629.4M | $104.4M | ||
| Q4 24 | $640.5M | $100.3M | ||
| Q3 24 | $640.5M | $99.9M | ||
| Q2 24 | $642.4M | $98.6M | ||
| Q1 24 | $646.1M | $94.7M |
净利润TDOCTOI
| Q4 25 | — | $-7.5M | ||
| Q3 25 | $-49.5M | $-16.5M | ||
| Q2 25 | $-32.7M | $-17.0M | ||
| Q1 25 | $-93.0M | $-19.6M | ||
| Q4 24 | — | $-13.2M | ||
| Q3 24 | $-33.3M | $-16.1M | ||
| Q2 24 | $-837.7M | $-15.5M | ||
| Q1 24 | $-81.9M | $-19.9M |
营业利润率TDOCTOI
| Q4 25 | -5.6% | -4.9% | ||
| Q3 25 | -8.3% | -5.9% | ||
| Q2 25 | -8.6% | -9.4% | ||
| Q1 25 | -19.2% | -9.5% | ||
| Q4 24 | -7.5% | -11.9% | ||
| Q3 24 | -6.9% | -13.9% | ||
| Q2 24 | -130.9% | -16.6% | ||
| Q1 24 | -13.5% | -19.0% |
净利率TDOCTOI
| Q4 25 | — | -5.3% | ||
| Q3 25 | -7.9% | -12.1% | ||
| Q2 25 | -5.2% | -14.2% | ||
| Q1 25 | -14.8% | -18.8% | ||
| Q4 24 | — | -13.1% | ||
| Q3 24 | -5.2% | -16.1% | ||
| Q2 24 | -130.4% | -15.7% | ||
| Q1 24 | -12.7% | -21.0% |
每股收益（稀释后）TDOCTOI
| Q4 25 | $-0.14 | $-0.04 | ||
| Q3 25 | $-0.28 | $-0.14 | ||
| Q2 25 | $-0.19 | $-0.15 | ||
| Q1 25 | $-0.53 | $-0.21 | ||
| Q4 24 | $-0.27 | $-0.14 | ||
| Q3 24 | $-0.19 | $-0.18 | ||
| Q2 24 | $-4.92 | $-0.17 | ||
| Q1 24 | $-0.49 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $781.1M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.4B | $-15.7M |
| 总资产 | $2.9B | $164.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TDOCTOI
| Q4 25 | $781.1M | — | ||
| Q3 25 | $726.2M | — | ||
| Q2 25 | $679.6M | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | $9.9M | ||
| Q1 24 | $1.1B | $29.8M |
股东权益TDOCTOI
| Q4 25 | $1.4B | $-15.7M | ||
| Q3 25 | $1.4B | $-12.3M | ||
| Q2 25 | $1.4B | $-9.0M | ||
| Q1 25 | $1.4B | $5.1M | ||
| Q4 24 | $1.5B | $3.6M | ||
| Q3 24 | $1.5B | $15.5M | ||
| Q2 24 | $1.5B | $29.2M | ||
| Q1 24 | $2.3B | $41.3M |
总资产TDOCTOI
| Q4 25 | $2.9B | $164.7M | ||
| Q3 25 | $2.9B | $163.6M | ||
| Q2 25 | $2.9B | $159.8M | ||
| Q1 25 | $3.4B | $164.0M | ||
| Q4 24 | $3.5B | $172.7M | ||
| Q3 24 | $3.5B | $179.2M | ||
| Q2 24 | $3.5B | $179.6M | ||
| Q1 24 | $4.3B | $204.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $87.7M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $85.1M | $2.2M |
| 自由现金流率自由现金流/营收 | 13.3% | 1.5% |
| 资本支出强度资本支出/营收 | 0.4% | 0.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $285.5M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流TDOCTOI
| Q4 25 | $87.7M | $3.2M | ||
| Q3 25 | $99.3M | $-12.6M | ||
| Q2 25 | $91.4M | $-10.2M | ||
| Q1 25 | $15.9M | $-5.0M | ||
| Q4 24 | $85.9M | $4.2M | ||
| Q3 24 | $110.2M | $819.0K | ||
| Q2 24 | $88.7M | $-15.7M | ||
| Q1 24 | $8.9M | $-15.9M |
自由现金流TDOCTOI
| Q4 25 | $85.1M | $2.2M | ||
| Q3 25 | $97.0M | $-13.2M | ||
| Q2 25 | $90.2M | $-11.4M | ||
| Q1 25 | $13.2M | $-5.3M | ||
| Q4 24 | $79.8M | $2.4M | ||
| Q3 24 | $108.6M | $417.0K | ||
| Q2 24 | $86.8M | $-17.5M | ||
| Q1 24 | $7.8M | $-16.5M |
自由现金流率TDOCTOI
| Q4 25 | 13.3% | 1.5% | ||
| Q3 25 | 15.5% | -9.7% | ||
| Q2 25 | 14.3% | -9.5% | ||
| Q1 25 | 2.1% | -5.1% | ||
| Q4 24 | 12.5% | 2.4% | ||
| Q3 24 | 17.0% | 0.4% | ||
| Q2 24 | 13.5% | -17.7% | ||
| Q1 24 | 1.2% | -17.4% |
资本支出强度TDOCTOI
| Q4 25 | 0.4% | 0.7% | ||
| Q3 25 | 0.4% | 0.4% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 1.0% | 1.8% | ||
| Q3 24 | 0.2% | 0.4% | ||
| Q2 24 | 0.3% | 1.9% | ||
| Q1 24 | 0.2% | 0.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TDOC
| Teladoc Health Integrated Care | $409.1M | 64% |
| Better Help | $233.2M | 36% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
